Cartesian Therapeutics (RNAC) Other Non Operating Income (2015 - 2026)
Cartesian Therapeutics' (RNAC) quarterly Other Non Operating Income came in at -$3000.0 in Q1 2026, down 100.04% on a QoQ basis from $7.5 million in Q4 2024.
Cartesian Therapeutics (RNAC) Other Non Operating Income (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 11 years of Other Non Operating Income data on file, last reported at -$3000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$3000.0 in Q1 2026; TTM through Mar 2026 was -$3000.0, a 100.04% decrease from a year earlier, with the FY2024 full-year figure at $606000.0, up 100.41% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$3000.0, down from $7.5 million in the prior quarter.
- Over the last five years, Other Non Operating Income for RNAC reached as high as $7.5 million in Q4 2024 and fell as low as -$149.6 million in Q4 2023.
- Historically, Other Non Operating Income has averaged -$12.4 million across 4 years, with a median of $12000.0 in 2022.
- Across the five-year window, Other Non Operating Income slumped 84441.81% in 2023 and soared 8433.33% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at -$177000.0 in 2022, then slumped by 84441.81% to -$149.6 million in 2023, then jumped by 105.01% to $7.5 million in 2024, then slumped by 100.04% to -$3000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$3000.0 in Q1 2026, $7.5 million in Q4 2024, and $250000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Cartesian Therapeutics | 210.28 Mn | 210.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2024 | 7.50 Mn |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 292,000.00 |
| Mar 31, 2024 | -6.89 Mn |
| Dec 31, 2023 | -149.64 Mn |
| Sep 30, 2023 | -3,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 255,000.00 |
| Dec 31, 2022 | -177,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 154,000.00 |
| Dec 31, 2021 | 515,000.00 |
| Sep 30, 2021 | -500,000.00 |
| Jun 30, 2021 | -14,000.00 |
| Dec 31, 2020 | 556,000.00 |
| Sep 30, 2020 | -500,000.00 |
| Jun 30, 2020 | 59,000.00 |
| Mar 31, 2020 | 82,000.00 |
| Sep 30, 2019 | -3,000.00 |